SCHEMBL2133262

SCHEMBL2133262

O=C1NCCN1[C@H]1CC[C@@H](C(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
DUSP3 P51452 1/20 0.42
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
TSHR P16473 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41
PMP22 Q01453 1/20 0.41
GABRA6 Q16445 1/20 0.41
GABRG1 Q8N1C3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380247 1.00 NPY5R (0.44) NPY5RKMT2AMEN1DUSP3GABRP
SCHEMBL3620191 0.90 NPY5R (0.46) NPY5RKMT2AMEN1DUSP3GABRP
SCHEMBL402931 0.90 NPY5R (0.46) NPY5RKMT2AMEN1DUSP3GABRP
SCHEMBL3627847 0.90 NPY5R (0.46) NPY5RKMT2AMEN1DUSP3GABRP
SCHEMBL14244119 0.84
SCHEMBL17893912 0.81 POLB (0.46) NPY5RKMT2AMEN1DUSP3GABRP
SCHEMBL11597215 0.79 NPY5R (0.39) NPY5RMMP1MMP2MMP3MMP7
SCHEMBL17977094 0.79 TGM2 (0.44) NPY5RKMT2ATSHRPOLBMMP1
SCHEMBL22614403 0.78 PDE7A (0.47) NPY5RMMP1MMP2MMP3MMP7
SCHEMBL22614405 0.78 PDE7A (0.47) NPY5RMMP1MMP2MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408767-B1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2013-07-10 EP claimed
EP-2408767-B1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2013-07-10 EP disclosed
US-20120101078-A1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS H. LUNDBRCK A/S (DK) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101078-A1 AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS NPY5R, NPY1R, NPY2R NPY5R 1/4885KMT2A 1750/4885MEN1 4129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.